BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25886177)

  • 1. Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.
    Feng YM; Feng CW; Chen SY; Hsieh HY; Chen YH; Hsu CD
    BMC Cancer; 2015 Mar; 15():134. PubMed ID: 25886177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MK-2206 induces cell cycle arrest and apoptosis in HepG2 cells and sensitizes TRAIL-mediated cell death.
    Jiao P; Zhou YS; Yang JX; Zhao YL; Liu QQ; Yuan C; Wang FZ
    Mol Cell Biochem; 2013 Oct; 382(1-2):217-24. PubMed ID: 23797319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
    Kim YW; Jang EJ; Kim CH; Lee JH
    Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase kinase 3 induces cell cycle arrest via p38 activation mediated Bmi-1 downregulation in hepatocellular carcinoma.
    Wang L; Chen C; Feng S; Lei P; Tian J
    Mol Med Rep; 2016 Jan; 13(1):243-8. PubMed ID: 26573508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juglone induces apoptosis and autophagy via modulation of mitogen-activated protein kinase pathways in human hepatocellular carcinoma cells.
    Wang P; Gao C; Wang W; Yao LP; Zhang J; Zhang SD; Li J; Fang SH; Fu YJ
    Food Chem Toxicol; 2018 Jun; 116(Pt B):40-50. PubMed ID: 29627502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
    Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
    Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
    Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling.
    Li Y; Cheng X; Chen C; Huijuan W; Zhao H; Liu W; Xiang Z; Wang Q
    Pathol Res Pract; 2020 Jan; 216(1):152701. PubMed ID: 31780054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
    Deng LJ; Hu LP; Peng QL; Yang XL; Bai LL; Yiu A; Li Y; Tian HY; Ye WC; Zhang DM
    Chem Biol Interact; 2014 Aug; 219():184-94. PubMed ID: 24954031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line.
    Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
    Mutat Res; 2013 Jul; 755(1):24-9. PubMed ID: 23660333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
    Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
    Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
    Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
    Choedon T; Dolma D; Kumar V
    J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.
    Li L; Zheng BB; Ma LS; Sun X; Chang JJ; Xie WD; Li X
    Acta Pharmacol Sin; 2014 Oct; 35(10):1311-22. PubMed ID: 25176399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.